Institut Suisse de Recherche Expérimentale sur le Cancer

A porous and elastic biomaterial for transplantations

Published:20.12.19 — Researchers from EPFL and UNIGE, in collaboration with the startup Volumina-Medical SA, have developed an innovative technique to allow for the direct transition from controllable in vitro cell culture to in vivo implantation. This technique uses chimeric particles: for in vitro cultures, these materials function like conventional microcarriers, but in part due to their surficial protection, they can come together to form an effective stem cell niche in vivo after subcutaneous injection.

A porous and elastic biomaterial for transplantations

Published:20.12.19 — Researchers from EPFL and UNIGE, in collaboration with the startup Volumina-Medical SA, have developed an innovative technique to allow for the direct transition from controllable in vitro cell culture to in vivo implantation. This technique uses chimeric particles: for in vitro cultures, these materials function like conventional microcarriers, but in part due to their surficial protection, they can come together to form an effective stem cell niche in vivo after subcutaneous injection.

The path of breast-to-brain cancer metastasis

Published:18.09.19 — Scientists at EPFL’s Swiss Institute for Experimental Cancer Research have discovered a signaling pathway that breast tumors exploit to metastasize to the brain. The work is published in Nature.